NanoBRET Approaches to Study Ligand Binding to GPCRs and RTKs
- 1 February 2018
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 39 (2), 136-147
- https://doi.org/10.1016/j.tips.2017.10.006
Abstract
No abstract availableFunding Information
- Seventh Framework Programme
- Innovative Medicines Initiative
- Promega
- Medical Research Council (MR/N020081/1)
- Biotechnology and Biological Sciences Research Council (115366, BB/L013827/1, BB/L019418/1)
- Australian Research Council (LP130100037)
- Seventh Framework Programme
This publication has 67 references indexed in Scilit:
- Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone SubstrateACS Chemical Biology, 2012
- Identification and Pharmacological Characterization of Multiple Allosteric Binding Sites on the Free Fatty Acid 1 ReceptorMolecular Pharmacology, 2012
- Secreted blood reporters: Insights and applicationsBiotechnology Advances, 2011
- Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic TherapiesGenes & Cancer, 2011
- Allosteric interactions across native adenosine‐A 3 receptor homodimers: quantification using single‐cell ligand‐binding kineticsThe FASEB Journal, 2011
- Long‐lasting target binding and rebinding as mechanisms to prolong in vivo drug actionBritish Journal of Pharmacology, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Molecular Diversity of VEGF-A as a Regulator of Its Biological ActivityMicrocirculation, 2009
- Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating systemProceedings of the National Academy of Sciences of the United States of America, 2008
- A general method for the covalent labeling of fusion proteins with small molecules in vivoNature Biotechnology, 2002